Tag: induced pluripotent stem cell market report

  • Induced Pluripotent Stem Cell (iPSC) Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Induced Pluripotent Stem Cell (iPSC) Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Induced Pluripotent Stem Cell (iPSC) Market Revenue Growth On Track For A 9.3% CAGR Through 2030

    The induced pluripotent stem cell (ipsc) market has demonstrated significant expansion in recent times. Projections indicate its expansion from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this growth is linked to breakthroughs in cellular reprogramming research, ethical concerns surrounding embryonic stem cells, enhanced funding for stem cell research, an increase in academic research collaborations, and the rising prevalence of chronic and degenerative diseases.

    The induced pluripotent stem cell (ipsc) market size is projected to experience substantial growth in the upcoming years, expanding to $5.75 billion by 2030 at a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period can be attributed to the broadening scope of regenerative medicine applications, a rising demand for personalized therapies, increasing investment in cell and gene therapy, the growing adoption of ipscs in neurological and cardiac research, and favorable regulatory support for advanced therapies. Key trends influencing the forecast period include the expanding use of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the proliferation of patient-specific cell line development, a heightened focus on ethical alternatives to embryonic stem cells, and ongoing advancements in reprogramming efficiency and cell stability.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=2515&type=smp&name=Induced%20Pluripotent%20Stem%20Cell%20%28iPSC%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Induced Pluripotent Stem Cell (iPSC) Market Growth Factors: What’s Supporting Expansion?

    The escalating occurrence of neurological conditions is expected to propel the growth of the induced pluripotent stem cell market moving forward. A neurological disorder refers to a medical ailment affecting the nervous system, including the brain, spinal cord, and nerves. Common examples include acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells offer the potential to study disease mechanisms and facilitate drug testing, thereby providing insights into the causes of neurological disorders and assisting in the development of regenerative therapies for conditions like Parkinson’s and Alzheimer’s disease. For instance, in October 2023, the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, reported that over 40% of the global population was living with a neurological condition, and the overall neurological disease burden is projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders is driving the growth of the induced pluripotent stem cell market.

    Induced Pluripotent Stem Cell (iPSC) Market Segment Breakdown: Which Categories Lead On Revenue?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    Induced Pluripotent Stem Cell (iPSC) Market Industry Trends: What’s Reshaping Demand?

    Key players in the Induced Pluripotent Stem Cell (iPSC) market are partnering to push iPSC Technology forward, aiming to boost regenerative medicine, refine disease modeling, speed up drug discovery, and create tailored therapeutic options. Induced Pluripotent Stem Cell (iPSC) technology involves scientific methods to revert adult somatic cells (like skin or blood cells) to a pluripotent condition, enabling them to transform into any body cell type. As an example, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology firm from Singapore, along with the Agency for Science, Technology and Research, a Singaporean statutory board, established joint laboratories focused on progressing cellular immunotherapies. This venture is backed by nearly S$30 million, highlighting Singapore’s dedication to improving biotechnology and healthcare solutions. The partnership seeks to establish scalable production methods for GMP-grade iPSC products, tackling the difficulties of moving lab breakthroughs into practical clinical treatments.

    Induced Pluripotent Stem Cell (iPSC) Market Leading Players And Competitive Positioning

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    View The Full Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://thebusinessresearchcompany.com/report/Induced-Pluripotent-Stem-Cell-Global-Market-Report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Induced Pluripotent Stem Cell (iPSC) Market Geographic Landscape: Which Region Leads Industry Growth?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Induced Pluripotent Stem Cell (iPSC) Market Size And Growth In 2026: Key Factors Shaping Future Demand

    Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

    Induced Pluripotent Stem Cell (iPSC) Market Revenue Growth On Track For A 9.3% CAGR Through 2030

    The induced pluripotent stem cell (ipsc) market has demonstrated significant expansion in recent times. Projections indicate its expansion from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this growth is linked to breakthroughs in cellular reprogramming research, ethical concerns surrounding embryonic stem cells, enhanced funding for stem cell research, an increase in academic research collaborations, and the rising prevalence of chronic and degenerative diseases.

    The induced pluripotent stem cell (ipsc) market size is projected to experience substantial growth in the upcoming years, expanding to $5.75 billion by 2030 at a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period can be attributed to the broadening scope of regenerative medicine applications, a rising demand for personalized therapies, increasing investment in cell and gene therapy, the growing adoption of ipscs in neurological and cardiac research, and favorable regulatory support for advanced therapies. Key trends influencing the forecast period include the expanding use of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the proliferation of patient-specific cell line development, a heightened focus on ethical alternatives to embryonic stem cells, and ongoing advancements in reprogramming efficiency and cell stability.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=2515&type=smp&name=Induced%20Pluripotent%20Stem%20Cell%20%28iPSC%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Induced Pluripotent Stem Cell (iPSC) Market Growth Factors: What’s Supporting Expansion?

    The escalating occurrence of neurological conditions is expected to propel the growth of the induced pluripotent stem cell market moving forward. A neurological disorder refers to a medical ailment affecting the nervous system, including the brain, spinal cord, and nerves. Common examples include acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells offer the potential to study disease mechanisms and facilitate drug testing, thereby providing insights into the causes of neurological disorders and assisting in the development of regenerative therapies for conditions like Parkinson’s and Alzheimer’s disease. For instance, in October 2023, the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, reported that over 40% of the global population was living with a neurological condition, and the overall neurological disease burden is projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders is driving the growth of the induced pluripotent stem cell market.

    Induced Pluripotent Stem Cell (iPSC) Market Segment Breakdown: Which Categories Lead On Revenue?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    Induced Pluripotent Stem Cell (iPSC) Market Industry Trends: What’s Reshaping Demand?

    Key players in the Induced Pluripotent Stem Cell (iPSC) market are partnering to push iPSC Technology forward, aiming to boost regenerative medicine, refine disease modeling, speed up drug discovery, and create tailored therapeutic options. Induced Pluripotent Stem Cell (iPSC) technology involves scientific methods to revert adult somatic cells (like skin or blood cells) to a pluripotent condition, enabling them to transform into any body cell type. As an example, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology firm from Singapore, along with the Agency for Science, Technology and Research, a Singaporean statutory board, established joint laboratories focused on progressing cellular immunotherapies. This venture is backed by nearly S$30 million, highlighting Singapore’s dedication to improving biotechnology and healthcare solutions. The partnership seeks to establish scalable production methods for GMP-grade iPSC products, tackling the difficulties of moving lab breakthroughs into practical clinical treatments.

    Induced Pluripotent Stem Cell (iPSC) Market Leading Players And Competitive Positioning

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    View The Full Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://thebusinessresearchcompany.com/report/Induced-Pluripotent-Stem-Cell-Global-Market-Report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Induced Pluripotent Stem Cell (iPSC) Market Geographic Landscape: Which Region Leads Industry Growth?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Expansion Is Reshaping Competitive Dynamics Across The Industry

    Induced Pluripotent Stem Cell (iPSC) Market Expansion Is Reshaping Competitive Dynamics Across The Industry

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Induced Pluripotent Stem Cell (iPSC) Market Expansion From $4.02 Billion In 2026 To $5.74 Billion In 2030

    The market for induced pluripotent stem cells (iPSCs) has experienced robust expansion, projecting a rise from $3.67 billion in 2025 to $4.02 billion by 2026, which reflects a compound annual growth rate of 9.5%. This upward trajectory during the preceding period was propelled by significant advancements in cellular reprogramming, a decrease in ethical debates surrounding embryonic stem cells, augmented investment in stem cell investigations, strengthened academic partnerships, and a growing incidence of chronic and degenerative health conditions.

    The induced pluripotent stem cell (ipsc) sector is poised for considerable expansion over the upcoming years, projecting a market value of $5.75 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.3%. This projected growth trajectory is largely propelled by the broadening scope of regenerative medicine, a heightened demand for tailored therapeutic approaches, escalating investments in cell and gene therapies, and the increasing utilization of ipscs in the investigation of neurological and cardiac conditions, alongside supportive regulatory frameworks for cutting-edge treatments. Key developments anticipated during this forecast period encompass a greater deployment of ipscs for disease modeling, their augmented use in drug discovery and safety assessments, the expansion of services for creating patient-specific cell lines, a heightened emphasis on ethical substitutes for embryonic stem cells, and progress in enhancing reprogramming efficiency and cellular durability.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    Induced Pluripotent Stem Cell (iPSC) Market Growth Momentum: Which Factors Are Influencing Demand?

    The rising incidence of conditions affecting the nervous system is anticipated to be a significant driver for the expansion of the induced pluripotent stem cell market. Neurological disorders encompass a range of ailments impacting the brain, spinal cord, and peripheral nerves, with examples including acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). These pluripotent stem cells are invaluable tools for dissecting disease pathways and facilitating drug discovery, thereby illuminating the origins of neurological ailments and assisting in the creation of restorative treatments for conditions like Parkinson’s and Alzheimer’s. For example, data released in October 2023 by the World Federation of Neurology (WFN), an international non-profit organization based in the UK, indicated that over 40% of the world’s population were affected by a neurological condition, with projections suggesting this burden could nearly double by 2050. Consequently, the escalating occurrence of neurological disorders is directly fueling the growth trajectory of the induced pluripotent stem cell market.

    Induced Pluripotent Stem Cell (iPSC) Market Segmentation: How Is The Market Structured Across Key Categories?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    Induced Pluripotent Stem Cell (iPSC) Market Trends Reshaping Industry Growth

    Major companies operating in the induced pluripotent stem cell (IPSC) market are collaborating to Advance iPSC Technology to enhance regenerative medicine applications, improve disease modeling, accelerate drug discovery, and develop personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology refers to the scientific process and methodologies used to reprogram adult somatic cells (such as skin or blood cells) back into a pluripotent state, making them capable of differentiating into any type of cell in the body. For instance, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, launched joint laboratories aimed at advancing cellular immunotherapies. The initiative is supported by close to S$30 million, emphasizing Singapore’s commitment to advancing biotechnology and healthcare solutions. The collaboration aims to develop scalable manufacturing processes for GMP-grade iPSC products, addressing the challenges of translating laboratory innovations into clinically viable therapies.

    Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape And Leading Companies

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Access The Complete Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Induced Pluripotent Stem Cell (iPSC) Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europewas the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Neurological Disorder Prevalence Fuels Growth Of The Induced Pluripotent Stem Cell Market Is Affecting The Direction Of The Induced Pluripotent Stem Cell (iPSC) Market

    Neurological Disorder Prevalence Fuels Growth Of The Induced Pluripotent Stem Cell Market Is Affecting The Direction Of The Induced Pluripotent Stem Cell (iPSC) Market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Expected Market Value Outlook For The Induced Pluripotent Stem Cell (iPSC) Market Through 2030?

    The market size for induced pluripotent stem cells (iPSC) has seen robust growth in recent years. It is projected to expand from $3.67 billion in 2025 to $4.02 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. This historical expansion is attributable to advancements in cellular reprogramming research, ethical considerations surrounding embryonic stem cells, increased investment in stem cell research, the rise of academic research collaborations, and the growing prevalence of chronic and degenerative diseases.

    The induced pluripotent stem cell (iPSC) market is projected for significant expansion in the coming years. This market is anticipated to reach $5.75 billion by 2030, showing a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this projected growth include the expanding applications of regenerative medicine, a heightened demand for personalized therapies, increased investment in cell and gene therapy, the growing use of iPSCs in neurological and cardiac research, and supportive regulatory environments for advanced therapies. Key trends during this period are expected to involve the increased application of iPSCs in disease modeling, wider adoption in drug discovery and toxicity testing, the development of more patient-specific cell lines, a growing emphasis on ethical alternatives to embryonic stem cells, and improvements in reprogramming efficiency and cell stability.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    What Influential Factors Are Boosting The Induced Pluripotent Stem Cell (iPSC) Market Demand?

    The escalating occurrence of neurological disorders is anticipated to stimulate the expansion of the induced pluripotent stem cell market in the foreseeable future. A neurological disorder describes a health condition affecting the nervous system, which includes the brain, spinal cord, and nerves. Common examples of these disorders encompass acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present avenues for researching disease mechanisms and conducting drug tests, offering valuable understanding into the origins of neurological disorders and assisting in the creation of regenerative therapies for conditions such as Parkinson’s and Alzheimer’s disease. For illustration, in October 2023, information from the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, revealed that over 40% of the global population was afflicted by a neurological condition, and the overall neurological disease burden was projected to nearly double by 2050. Thus, the rising incidence of neurological disorders is propelling the growth of the induced pluripotent stem cell market.

    What Key Segment Areas Are Included In The Induced Pluripotent Stem Cell (iPSC) Market Assessment?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    Which Trends Are Expected To Shape The Induced Pluripotent Stem Cell (iPSC) Market?

    Key enterprises within the induced pluripotent stem cell (IPSC) market are forming partnerships to propel iPSC Technology forward, with their collective aim being to bolster applications in regenerative medicine, refine disease modeling techniques, expedite drug discovery efforts, and create customized therapeutic options. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific procedures and methods employed to revert adult somatic cells (like skin or blood cells) into a pluripotent state, enabling these cells to then differentiate into any type of cell within the body. Illustrating this trend, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology firm from Singapore, along with the Agency for Science, Technology and Research, a statutory board also based in Singapore, inaugurated shared laboratories dedicated to advancing cellular immunotherapies. Financial backing for this endeavor totals nearly S$30 million, highlighting Singapore’s dedication to fostering advancements in both biotechnology and healthcare solutions. The primary goal of this partnership is to establish manufacturing processes for GMP-grade iPSC products that can be scaled up, directly addressing the difficulties in moving laboratory discoveries into therapies that can be used clinically.

    Who Are The Firms Contributing To The Induced Pluripotent Stem Cell (iPSC) Market Ecosystem?

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Access The Complete Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Which Region Leads The Induced Pluripotent Stem Cell (iPSC) Market By Size?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Induced Pluripotent Stem Cell (iPSC) Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

    Noise Mitigation System Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/noise-mitigation-system-global-market-report

    Automotive Noise Insulation Parts Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/automotive-noise-insulation-parts-global-market-report

    Architectural Acoustic Panels Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/architectural-acoustic-panels-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global iPSC market projected to reach $5.74 billion by 2030 at 9.3% CAGR

    Global iPSC market projected to reach $5.74 billion by 2030 at 9.3% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Will The Market Value Of The Induced Pluripotent Stem Cell (iPSC) Market Grow Between 2026 And 2030?

    The induced pluripotent stem cell (ipsc) market has experienced substantial expansion over the past few years. Its valuation is expected to rise from $3.67 billion in 2025 to $4.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. This historical increase can be ascribed to advancements in cellular reprogramming studies, ethical considerations surrounding embryonic stem cells, increased financial backing for stem cell research, an expansion in academic research collaborations, and the rising occurrence of chronic and degenerative conditions.

    The induced pluripotent stem cell (ipsc) market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. Several factors are contributing to this expansion during the forecast timeframe, including the broadening of regenerative medicine applications, a heightened need for personalized treatments, increasing capital invested in cell and gene therapies, the growing use of ipscs in studies related to neurological and cardiac conditions, and supportive regulatory frameworks for advanced therapeutic approaches. Key developments expected within this period encompass the increasing application of ipscs in creating disease models, their wider integration into drug discovery and assessments of toxicity, the expansion of methods for developing patient-specific cell lines, a greater emphasis on finding ethical substitutes for embryonic stem cells, and improvements in the effectiveness of reprogramming as well as cellular stability.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    What Primary Drivers Are Shaping The Induced Pluripotent Stem Cell (iPSC) Market?

    The rising occurrence of neurological disorders is anticipated to propel the expansion of the induced pluripotent stem cell market. A neurological disorder refers to a medical condition impacting the nervous system, which includes the brain, spinal cord, and nerves. Prevalent examples of such disorders are acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present significant potential for investigating disease mechanisms and conducting drug testing, thereby offering deeper insights into the origins of neurological disorders and aiding in the creation of regenerative therapies for conditions like Parkinson’s and Alzheimer’s disease. For instance, in October 2023, the World Federation of Neurology (WFN), an international nonprofit neurological organization based in the UK, stated that more than 40% of the global population was living with a neurological condition, and the overall neurological disease burden is projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders is a key driver for the growth of the induced pluripotent stem cell market.

    What Are The Main Segments Within The Induced Pluripotent Stem Cell (iPSC) Market Segment Structure?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    What Trends Are Affecting The Growth Of The Induced Pluripotent Stem Cell (iPSC) Market?

    Major companies in the induced pluripotent stem cell (IPSC) market are collaborating to advance iPSC technology, with the goals of enhancing regenerative medicine applications, improving disease modeling, accelerating drug discovery, and developing personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology refers to the scientific processes and methods used to reprogram adult somatic cells, such as skin or blood cells, back into a pluripotent state, making them capable of differentiating into any cell type in the body. For instance, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, launched joint laboratories focused on advancing cellular immunotherapies. This initiative is supported by close to S$30 million, highlighting Singapore’s commitment to progressing biotechnology and healthcare solutions. The collaboration intends to develop scalable manufacturing processes for GMP-grade iPSC products, addressing the challenges of translating laboratory innovations into clinically viable therapies.

    Who Are The Companies Participating In The Induced Pluripotent Stem Cell (iPSC) Market?

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Get The Full Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Which Region Leads The Induced Pluripotent Stem Cell (iPSC) Market In Terms Of Market Share?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Induced Pluripotent Stem Cell (iPSC) Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

    Stem Cell Assay Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

    Human Embryonic Stem Cells Market Report 2026

    https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

    Stem Cells Therapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Revenue Expected to Reach $5.74 Billion by 2030 with 9.3% CAGR

    Induced Pluripotent Stem Cell (iPSC) Market Revenue Expected to Reach $5.74 Billion by 2030 with 9.3% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Market Size Of The Induced Pluripotent Stem Cell (iPSC) Market In 2026 And What Value Is Projected For 2030?

    The induced pluripotent stem cell (ipsc) market has demonstrated strong growth over recent years. It is anticipated to expand from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to several key factors, including significant breakthroughs in cellular reprogramming research, ethical issues surrounding embryonic stem cells, increased financial support for stem cell investigations, the proliferation of academic research collaborations, and the rising occurrence of chronic and degenerative conditions.

    The induced pluripotent stem cell (ipsc) market is anticipated to experience substantial growth over the next few years. This market is projected to reach $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period can be attributed to the broadening of regenerative medicine applications, a surging demand for personalized therapies, increased investment in cell and gene therapy, the growing use of ipscs in neurological and cardiac research, and supportive regulatory environments for advanced therapeutic strategies. Noteworthy trends throughout the projection period involve the expanding utilization of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the development of patient-specific cell lines, a heightened focus on ethical alternatives to embryonic stem cells, and continuous improvements in reprogramming efficiency and cell stability.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    What Major Drivers Are Influencing Demand In The Induced Pluripotent Stem Cell (iPSC) Market?

    The rising incidence of neurological conditions is anticipated to boost the expansion of the induced pluripotent stem cell market. A neurological disorder describes a medical state impacting the nervous system, encompassing the brain, spinal cord, and nerves. Examples of prevalent neurological disorders include acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present opportunities for investigating disease mechanisms, conducting drug tests, uncovering the roots of neurological disorders, and facilitating the creation of regenerative treatments for ailments such as Parkinson’s and Alzheimer’s disease. As evidence, in October 2023, the World Federation of Neurology (WFN), an international nonprofit neurological organization based in the UK, reported that over 40% of the world’s population was afflicted with a neurological condition, with the total neurological disease burden expected to nearly double by 2050. Consequently, the increasing occurrence of neurological disorders is propelling the induced pluripotent stem cell market’s growth.

    What Are The Key Segments Of The Induced Pluripotent Stem Cell (iPSC) Market?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    Which Upcoming Trends Are Expected To Influence The Induced Pluripotent Stem Cell (iPSC) Market?

    Leading companies in the induced pluripotent stem cell (IPSC) market are engaging in collaborations to advance iPSC technology, aiming to enhance regenerative medicine applications, improve disease modeling, accelerate drug discovery, and develop personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific process and methodologies utilized to reprogram adult somatic cells, such as skin or blood cells, back into a pluripotent state, enabling them to differentiate into any cell type in the body. For example, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, inaugurated joint laboratories dedicated to advancing cellular immunotherapies. This initiative is backed by close to S$30 million, underscoring Singapore’s commitment to fostering biotechnology and healthcare solutions. The collaboration intends to develop scalable manufacturing processes for GMP-grade iPSC products, thereby addressing the challenges involved in translating laboratory innovations into clinically viable therapies.

    Who Are The Leading Companies Operating In The Induced Pluripotent Stem Cell (iPSC) Market?

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Read the full induced pluripotent stem cell (ipsc) market report here:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Which Region Shows The Strongest Potential For Future Growth In The Induced Pluripotent Stem Cell (iPSC) Market?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Induced Pluripotent Stem Cell (iPSC) Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

    Noise Mitigation System Global Market Report

    https://www.thebusinessresearchcompany.com/report/noise-mitigation-system-global-market-report

    Automotive Noise Insulation Parts Global Market Report

    https://www.thebusinessresearchcompany.com/report/automotive-noise-insulation-parts-global-market-report

    Architectural Acoustic Panels Global Market Report

    https://www.thebusinessresearchcompany.com/report/architectural-acoustic-panels-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Outlook 2026–2035: Growth Drivers and Industry Forecast

    Induced Pluripotent Stem Cell (iPSC) Market Outlook 2026–2035: Growth Drivers and Industry Forecast

    Uncover key drivers, emerging technologies, and competitive movements shaping the induced pluripotent stem cell (ipsc) market from 2026–2035 with trusted insights from The Business Research Company

    What size range is anticipated for the Induced Pluripotent Stem Cell (iPSC) Market from 2026 to 2030?

    The market for induced pluripotent stem cells (ipsc) has experienced significant expansion in recent years. This market is expected to increase from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth trajectory is primarily driven by advancements in cellular reprogramming research, ethical considerations concerning embryonic stem cells, enhanced funding for stem cell research, an uptick in academic research collaborations, and the rising occurrence of chronic and degenerative diseases.

    The induced pluripotent stem cell (ipsc) market is anticipated to experience robust growth in the coming years. It is projected to achieve a size of $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period can be attributed to the broadening of regenerative medicine applications, increasing demand for personalized therapies, rising investment in cell and gene therapy, greater adoption of ipscs in neurological and cardiac research, and favorable regulatory support for advanced therapies. Notable trends expected in this period include the expanding utilization of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the development of more patient-specific cell lines, a growing focus on ethical alternatives to embryonic stem cells, and advancements in reprogramming efficiency and cell stability.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    What Drivers Are Affecting Demand In The Induced Pluripotent Stem Cell (iPSC) Market?

    The rising incidence of neurological conditions is anticipated to drive expansion in the induced pluripotent stem cell market in the foreseeable future. A neurological disorder is defined as a health ailment impacting the nervous system, which encompasses the brain, spinal cord, and nerves. Frequently encountered neurological disorders include acute spinal cord injury, Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), among others. Pluripotent stem cells present an opportunity for investigating disease mechanisms and performing drug tests, thereby offering understanding into the origins of neurological disorders and assisting in creating regenerative treatments for ailments like Parkinson’s and Alzheimer’s disease. As an illustration, figures from October 2023, released by the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, indicated that over 40% of the world’s population was afflicted by a neurological condition, with the total neurological disease burden forecast to almost double by 2050. Consequently, the growing occurrence of neurological disorders is fueling the expansion of the induced pluripotent stem cell market.

    Which Segments Are Gaining Traction In The Induced Pluripotent Stem Cell (iPSC) Market?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    What Trends Are Projected To Support The Growth Of The Induced Pluripotent Stem Cell (iPSC) Market?

    Leading companies in the Induced Pluripotent Stem Cell (IPSC) market are engaging in collaborations to further develop iPSC Technology, aiming to enhance regenerative medicine applications, refine disease modeling, accelerate drug discovery, and create personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific procedures and methods used to revert adult somatic cells, such as those from skin or blood, back into a pluripotent state, enabling them to differentiate into any cell type within the body. For example, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology company based in Singapore, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, initiated joint laboratories with the objective of advancing cellular immunotherapies. This initiative, supported by close to S$30 million, highlights Singapore’s commitment to progress in biotechnology and healthcare solutions. The collaboration intends to establish scalable manufacturing processes for GMP-grade iPSC products, thereby addressing the challenges of transitioning laboratory innovations into clinically viable therapies.

    Who Are The Top-Performing Companies In The Induced Pluripotent Stem Cell (iPSC) Market In Recent Years?

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    How Does The Induced Pluripotent Stem Cell (iPSC) Market Perform Across Major Global Regions?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Induced Pluripotent Stem Cell (iPSC) Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

    Stem Cell Assay Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

    Human Embryonic Stem Cells Market Report 2026

    https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

    Stem Cells Therapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Outlook 2026–2035: Growth Drivers and Industry Forecast

    Uncover key drivers, emerging technologies, and competitive movements shaping the induced pluripotent stem cell (ipsc) market from 2026–2035 with trusted insights from The Business Research Company

    What size range is anticipated for the Induced Pluripotent Stem Cell (iPSC) Market from 2026 to 2030?

    The market for induced pluripotent stem cells (ipsc) has experienced significant expansion in recent years. This market is expected to increase from $3.67 billion in 2025 to $4.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth trajectory is primarily driven by advancements in cellular reprogramming research, ethical considerations concerning embryonic stem cells, enhanced funding for stem cell research, an uptick in academic research collaborations, and the rising occurrence of chronic and degenerative diseases.

    The induced pluripotent stem cell (ipsc) market is anticipated to experience robust growth in the coming years. It is projected to achieve a size of $5.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period can be attributed to the broadening of regenerative medicine applications, increasing demand for personalized therapies, rising investment in cell and gene therapy, greater adoption of ipscs in neurological and cardiac research, and favorable regulatory support for advanced therapies. Notable trends expected in this period include the expanding utilization of ipscs in disease modeling, their increasing integration into drug discovery and toxicity testing, the development of more patient-specific cell lines, a growing focus on ethical alternatives to embryonic stem cells, and advancements in reprogramming efficiency and cell stability.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    What Drivers Are Affecting Demand In The Induced Pluripotent Stem Cell (iPSC) Market?

    The rising incidence of neurological conditions is anticipated to drive expansion in the induced pluripotent stem cell market in the foreseeable future. A neurological disorder is defined as a health ailment impacting the nervous system, which encompasses the brain, spinal cord, and nerves. Frequently encountered neurological disorders include acute spinal cord injury, Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), among others. Pluripotent stem cells present an opportunity for investigating disease mechanisms and performing drug tests, thereby offering understanding into the origins of neurological disorders and assisting in creating regenerative treatments for ailments like Parkinson’s and Alzheimer’s disease. As an illustration, figures from October 2023, released by the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, indicated that over 40% of the world’s population was afflicted by a neurological condition, with the total neurological disease burden forecast to almost double by 2050. Consequently, the growing occurrence of neurological disorders is fueling the expansion of the induced pluripotent stem cell market.

    Which Segments Are Gaining Traction In The Induced Pluripotent Stem Cell (iPSC) Market?

    The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

    What Trends Are Projected To Support The Growth Of The Induced Pluripotent Stem Cell (iPSC) Market?

    Leading companies in the Induced Pluripotent Stem Cell (IPSC) market are engaging in collaborations to further develop iPSC Technology, aiming to enhance regenerative medicine applications, refine disease modeling, accelerate drug discovery, and create personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology describes the scientific procedures and methods used to revert adult somatic cells, such as those from skin or blood, back into a pluripotent state, enabling them to differentiate into any cell type within the body. For example, in April 2024, SCG Cell Therapy Pte Ltd, a biotechnology company based in Singapore, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, initiated joint laboratories with the objective of advancing cellular immunotherapies. This initiative, supported by close to S$30 million, highlights Singapore’s commitment to progress in biotechnology and healthcare solutions. The collaboration intends to establish scalable manufacturing processes for GMP-grade iPSC products, thereby addressing the challenges of transitioning laboratory innovations into clinically viable therapies.

    Who Are The Top-Performing Companies In The Induced Pluripotent Stem Cell (iPSC) Market In Recent Years?

    Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    How Does The Induced Pluripotent Stem Cell (iPSC) Market Perform Across Major Global Regions?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Induced Pluripotent Stem Cell (iPSC) Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

    Stem Cell Assay Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

    Human Embryonic Stem Cells Market Report 2026

    https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

    Stem Cells Therapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Will The Induced Pluripotent Stem Cell (iPSC) Market Expand At A CAGR Of 9.6% Through 2029?

    How Will The Induced Pluripotent Stem Cell (iPSC) Market Expand At A CAGR Of 9.6% Through 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Will The Induced Pluripotent Stem Cell (iPSC) Market Valuation Change Between Now And 2029?

    In recent times, the market size for induced pluripotent stem cell (ipsc) has witnessed a swift expansion. Projected to escalate from $3.3 billion in 2024 to $3.67 billion in 2025, it is expected to boast a compound annual growth rate (CAGR) of 11.3%. The historical growth can be associated with factors such as increasing healthcare expenditure, escalated funding, growing acknowledgment of the therapeutic potential of stem cell products, employment of induced pluripotent stem cell (IPSC) in drug discovery, rising demand for personalized medication, and the cost-effective advantages of IPSC in drug exploration.

    Expectations are high for significant expansion in the induced pluripotent stem cell (ipsc) market over the upcoming years, with a projected growth reaching $5.29 billion by 2029. This growth translates to a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this expected growth include an increasing number of chronic and genetic diseases, advancements in genomic projects and disease models derived from IPSC, as well as governmental initiatives and growth in technology. Key trends within the forecast period include the use of pluripotent stem cells in treating Parkinson’s disease (PD), increase in strategic collaborations and partnerships, the advancement of induced pluripotent stem cell IPSC-derived nk cells and cell therapy, investments in research and development of regenerative medicine, the introduction of IPSC expansion medium, personalized IPSC development, and potential treatment for type I diabetes using pluripotent stem cells.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    What Growth-Enabling Forces Are Impacting The Induced Pluripotent Stem Cell (iPSC) Market?

    The significant surge in chronic health conditions is a key factor fuelling the expansion of the induced pluripotent stem cell market. Chronic diseases such as cardio conditions, cancer, stroke, and diabetes can be effectively managed with the help of induced pluripotent stem cells. These are derived from the tissues of a child or an adult and are genetically altered to mimic the behavior of embryonic stem cells. The Partnership to Fight Chronic Disorder (PFCD)’s recent report indicates that approximately 45% of the 133 million Americans have at least one chronic health condition. Furthermore, approximately 1.7 million deaths in the USA, constituting seven out of every ten deaths, are related to these chronic conditions. These deaths can potentially be kept in check using induced pluripotent stem cell treatment. Such an increase in chronic ailments is spurring the need for the induced pluripotent stem cell treatment market.

    What Are The Main Segment Classifications In The Induced Pluripotent Stem Cell (iPSC) Market?

    The induced pluripotent stem cell (ipsc)market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing; Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair; Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research; Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research; Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling; Cardiomyocytes For Heart Disease Studies; Endothelial Cells For Vascular Research

    Which Emerging Trends Are Reshaping The Induced Pluripotent Stem Cell (iPSC) Market Landscape?

    Firms operating within the Induced Pluripotent stem cell market are exploring strategic alliances and collaborations as a means to break into new areas and widen their product offerings. For instance, Bristol Myers Squibb and Century Therapeutics established a strategic alliance in January 2022 with the goal of creating IPSC-derived allogenic cell treatments for acute myeloid leukemia and multiple myeloma. Further, in May 2022, Evotec and Sernova declared a strategic partnership to work on the development of IPSC-based beta cell replacement therapies for the treatment of type 1 and type 2 diabetes.

    Which Firms Are Driving Innovation Within The Induced Pluripotent Stem Cell (iPSC) Market?

    Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    What Are The Emerging Regional Trends Driving The Induced Pluripotent Stem Cell (iPSC) Market?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2025, By The Business Research Company

    Stem Cell Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

    Stem Cell Cord Blood Banking Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

    Stem Cells Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Induced Pluripotent Stem Cell (iPSC) Market Expansion Outlook: $5.29 Billion by 2029 Forecast

    Induced Pluripotent Stem Cell (iPSC) Market Expansion Outlook: $5.29 Billion by 2029 Forecast

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Forecasted Market Size Estimates For The Induced Pluripotent Stem Cell (iPSC) Market Between 2025 And 2029?

    The induced pluripotent stem cell (ipsc) market has experienced swift expansion in recent years. Projections indicate its value will increase from $3.3 billion in 2024 to $3.67 billion in 2025, at a compound annual growth rate (CAGR) of 11.3%. This historical growth can be attributed to factors such as increasing healthcare expenditure, a rise in funding, a heightened awareness of the medicinal potential of stem cell products, the use of induced pluripotent stem cell (IPSC) in drug discovery, a growing demand for personalized medicine, and the cost-effective advantages of IPSC for drug discovery.

    The induced pluripotent stem cell (ipsc) market is projected for substantial expansion in the coming years. Its size is expected to reach $5.29 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.6%. Factors driving this growth during the forecast period include the rising incidence of chronic and genetic diseases, expanding genomic projects, the creation of IPSC-derived disease models, governmental support, and swift technological advancements. Key trends expected over this period encompass the development of pluripotent stem cells for Parkinson’s disease (PD) and Type I diabetes, various strategic collaborations and partnerships, the advancement of induced pluripotent stem cell IPSC-derived NK cells, the application of induced pluripotent stem cell (IPSC) in cell therapy, increased investment in regenerative medicine research and development, and the creation of IPSC expansion media and personalized IPSCs.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

    Which Factors And Drivers Are Influencing The Induced Pluripotent Stem Cell (iPSC) Market In 2025?

    The induced pluripotent stem cell market’s expansion is significantly propelled by the rising occurrence of chronic conditions. Induced pluripotent stem cells offer a treatment option for chronic ailments like heart disease, cancer, stroke, and diabetes. These stem cells are derived from various tissues of a child or an adult and are genetically altered to mimic the behavior of embryonic stem cells. A report from the Partnership to Fight Chronic Disorder (PFCD) revealed that 45% of 133 million Americans were affected by at least one chronic disorder. Furthermore, an estimated 7 out of 10 deaths in the USA, totaling around 1.7 million, are attributed to chronic disorders, with induced pluripotent stem cell treatment potentially offering control over these fatalities. Consequently, the escalating rates of chronic diseases are fueling the demand within the induced pluripotent stem cell treatment market.

    What Are The Different Segment Classifications Within The Induced Pluripotent Stem Cell (iPSC) Market?

    The induced pluripotent stem cell (ipsc)market covered in this report is segmented –

    1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

    2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

    3) By End-User: Hospitals, Research Laboratories

    Subsegments:

    1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing; Disease Modeling And Regenerative Therapies

    2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair; Fibroblast-Based Disease Research

    3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research; Skin Regeneration Therapies

    4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research; Amniotic Fluid-Based Regenerative Applications

    5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling; Cardiomyocytes For Heart Disease Studies; Endothelial Cells For Vascular Research

    What Trends Are Expected To Drive The Induced Pluripotent Stem Cell (iPSC) Market?

    Businesses operating in the Induced Pluripotent stem cell market are actively seeking strategic partnerships and collaborations to enable their entry into new geographical areas and to expand their product portfolios. For instance, in January 2022, Bristol Myers Squibb and Century Therapeutics formed a strategic collaboration dedicated to developing IPSC-derived allogenic cell therapies for addressing acute myeloid leukemia and multiple myeloma. Moreover, in May 2022, Evotec and Sernova announced a strategic partnership aimed at advancing IPSC-based beta cell replacement therapy for the management of type 1 and type 2 diabetes.

    Which Key Market Players Are Investing In Expansion And Innovation Of Induced Pluripotent Stem Cell (iPSC) Market?

    Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

    Which Global Regions Are Influencing The Competitive Landscape Of The Induced Pluripotent Stem Cell (iPSC) Market?

    North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Induced Pluripotent Stem Cell (iPSC) Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

    Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2025, By The Business Research Company

    Stem Cell Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

    Stem Cell Cord Blood Banking Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

    Stem Cells Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model